Sarcopenia is a condition characterized by decreased skeletal muscle mass due to physiological ageing or to a concomitant disease such as neoplasia. In cancer patients, a low lean body mass is suggested to be a negative prognostic factor for survival and for the development of dose-limiting chemotherapy toxicities irrespective of disease stage.
Prognostic role of sarcopenia in metastatic colorectal cancer patients during first-line chemotherapy: A retrospective study / Maddalena, C., Ponsiglione, A., Camera, L., Santarpia, L., Pasanisi, F., Bruzzese, D., Panico, C., Fiore, G., Camardella, S., Caramia, T., Farinaro, A., De Placido, S., Carlomagno, C.. - In: WORLD JOURNAL OF CLINICAL ONCOLOGY. - ISSN 2218-4333. - 12:5(2021), pp. 355-366. [10.5306/wjco.v12.i5.355]
Prognostic role of sarcopenia in metastatic colorectal cancer patients during first-line chemotherapy: A retrospective study
Maddalena, Chiara;Ponsiglione, Andrea;Camera, Luigi;Santarpia, Lidia;Pasanisi, Fabrizio;Bruzzese, Dario;Panico, Camilla;Fiore, Giovanni;Camardella, Simona;Caramia, Tolomeo;Farinaro, Alessia;De Placido, Sabino;Carlomagno, Chiara
2021
Abstract
Sarcopenia is a condition characterized by decreased skeletal muscle mass due to physiological ageing or to a concomitant disease such as neoplasia. In cancer patients, a low lean body mass is suggested to be a negative prognostic factor for survival and for the development of dose-limiting chemotherapy toxicities irrespective of disease stage.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
